Results 41 to 50 of about 8,608 (238)

Hecken: „Gesetze werden im Treibsand versanden”

Monitor Versorgungsforschung
So selten sich eine schon des Öfteren von Daniela Teichert, der Vorstandsvorsitzenden der AOK Nordost, eingeforderte „Allianz der Willigen“ formiert, so gering wird die Chance sein, dass Robert Habecks „Allianz der Vernünftigen“ die noch ausstehenden ...
Peter Stegmaier
doaj   +1 more source

End-of-life care preferences of older patients with multimorbidity: protocol of a mixed-methods systematic review

BMJ Open, 2020
Introduction End-of-life care is an essential task performed by most healthcare providers and often involves decision-making about how and where patients want to receive care.
Marjan Van Den Akker, Odette Wegwarth, Joerg J Meerpohl, Sharon E Straus, Tammy Hoffmann, Ferdinand M Gerlach, Christine Schmucker, Ana Isabel González-González, Jeanet Blom, Truc Sophia Nguyen, Kristian Röttger, Christiane Muth, Maria-Sophie Brueckle   +12 more
doaj   +1 more source

Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting [PDF]

, 2016
BACKGROUND: Asthma affects an estimated 300 million people worldwide with the condition associated with significant healthcare utilisation costs and a large impact on patient quality of life.
J. Hahn-Pedersen, J. Nørgaard Andreasen, M. Taylor, M. Worm, W. Green   +4 more
core   +1 more source

The Hospital-Wide Implementation of Shared Decision-Making.

Deutsches Ärzteblatt International, 2021
The German Law on Patients’ Rights (Patientenrechtegesetz) stipulates that all medically reasonable treatment options must be taken into consideration by the physician and the patient, in the light of the best available medical evidence and the patient’s
F. Geiger, A. Novelli, Daniela Berg, C. Hacke, L. Sundmacher, Olga Kopeleva, F. Scheibler, J. Rüffer, Christine Kuch, Kai Wehkamp   +9 more
semanticscholar   +1 more source

„Eine Allianz der evidenzbasiert Entscheidenden gegen Populismus“

Monitor Versorgungsforschung
Im Doppel-Titelinterview zum Jahresstart 2024 mit „Monitor Versorgungsforschung“ diskutieren Prof. Josef Hecken, der unparteiische Vorsitzende des Gemeinsamen Bundesausschusses (G-BA), und Univ.-Prof. Dr. med.
Prof. Josef Hecken, Univ.-Prof. Dr. med. Wolfgang Hoffmann, Peter Stegmaier   +2 more
doaj   +1 more source

HTA und aktuelle Herausforderungen: Harmonisierung, Real World Data und Surrogatparameter

GMS Medizinische Informatik, Biometrie und Epidemiologie, 2018
Health Technology Assessment is one of the standard instruments in support of the decision-making to define the public health services both internationally and in the German health care system.
Rüther, Alric, Herrmann, Kirsten H., Hebborn, Ansgar, Perleth, Matthias, Schwarzer, Ruth, Schürmann, Christoph, Sieben, Wiebke, Gillhaus, Johanna, Goertz, Ralf, Jeratsch, Ulli, Leverkus, Friedhelm, Schramm, Wendelin   +11 more
doaj   +1 more source

Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective

European Journal of Health Economics, 2021
The transferability of the EU joint clinical assessment (JCA) reports for pharmaceuticals for the German benefit assessment was evaluated by systematically comparing EU JCA and German clinical assessments (CA) based on established assessment elements for
A. Kisser, Joschua Knieriemen, A. Fasan, Karolin Eberle, Sara Hogger, Sebastian Werner, Tina Taube, A. Rasch   +7 more
semanticscholar   +1 more source

A cost‐effectiveness analysis of breast cancer treatment in certified versus non‐certified hospitals in Germany

International Journal of Cancer, EarlyView.
What's New? This study is the first to quantify the cost‐effectiveness of breast cancer treatment in German Cancer Society‐certified hospitals using real‐world data from over 140,000 patients. Analysis on certification‐related costs and survival outcomes demonstrates that high‐quality multidisciplinary care at certified hospitals delivers substantial ...
Min‐Wai Lwin, Olaf Schoffer, Christoph Streissnig, Pauline Wimberger, Michael Gerken, Veronika Bierbaum, Christoph Bobeth, Martin Rößler, Patrik Dröge, Thomas Ruhnke, Christian Günster, Kees Kleihues‐van Tol, Theresa Link, Anton Scharl, Elisabeth C. Sturm‐Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt, Michael Schlander   +20 more
wiley   +1 more source

Oncology drugs and added benefit: insights from 3 European health technology assessment agencies on the role of efficacy endpoints

Journal of Medical Economics, 2021
Objective This study aimed to understand the impact of different efficacy endpoints on reimbursement decisions made by health technology assessment (HTA) bodies.
N. Smith, A. Fu, T. Fisher, D. Meletiche, V. Pawar   +4 more
semanticscholar   +1 more source

Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non‐Relapse Mortality

European Journal of Haematology, EarlyView.
ABSTRACT Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) offers curative potential for many hematological malignancies; however, outcomes may be adversely affected by infections and transplant‐associated complications, contributing to non‐relapse mortality (NRM).
Lara Bischof, Katharina Egger‐Heidrich, Martin Schneider, Gregor Friedrich, Anna Massow, Johanna Vogelsang, Franziska Schmidt, Matthias Hänel, Thomas Illmer, Lynn Leppla, Alexandra Teynor, Sabina de Geest, Gabriele Muelller, Klaus H. Metzeler, Martin Bornhäuser, Uwe Platzbecker, Jan Moritz Middeke, Vladan Vučinić   +17 more
wiley   +1 more source